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Citrulline and the reaction of citrullination  
L-citrulline (L-Cit) is a ornithine derivative 
which is related to arginine (Fig. 1). It is 
found in nature in two forms: as a free amino 
acid or as an amino acid constituent of 
proteins.  
Three enzymes are involved in the 
metabolism of free form of citrulline. Two of 
them originate from the urea cycle: ornithine 
carbamoyltransferase, which produces L-Cit, 
and argininosuccinate synthetase which 
converts L-Cit into argininosuccinate. The 
third enzyme, NO synthase, produces L-Cit as 
a by-product in NO production (Curis et al. 
2005). Due to the importance of the L-Cit in 
the protein structure, its formation and 
function will be consider in details. Cit is not 
encoded by a t-RNA. The only way in which 
L-Cit can be introduced into proteins is the 
posttranslational modification of L-Arg - 
called citrullination. During the reaction, the 
easily protonated guanidine group of L-Arg is 
modified into an uncharged carbonyl group 
(Vossenaar et al. 2003). The most important 
results of this modification are: an altered 
isoelectric point of the protein, an alteration in 
the charge distribution and hydrogen or ionic 
bonds formation in the protein structure. The 
extensive citrullination of a protein may alter 
its tertiary structure, interaction with other 
molecules, cleavage regions, and its 
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solubility. The advanced degree of 
citrullination leads to denaturation of the 
protein (Tarcsa et al. 1996a; Vossenaar et al. 
2003; Chang et al. 2005; Nakayama-Hamada 
et al. 2008). 
 
Figure 1. L-citrulline. 
 
Mechanism of reaction 
Citrullination is catalyzed by the action of 
Ca
2+
-dependent enzymes belonging to the 
peptidylarginine deiminase family (EC 
3.5.3.15). To date, five mammalian PAD 
genes have been identified. They are localized 
within the 334,7kb region in cluster 1p36.1. 
Because of high nucleotide sequence 
homology (59-71% identity) (Chavanas  
et al. 2006), and  the conservative cluster 
organization it is postulated that PAD are the 
result of genetic duplications occurring before 
the divergence of mammalian species. The 
localization of enzymes and their mRNA with 
corresponding tissues is shown in Table 1 
(Vossenaar et al. 2003; Suzuki et al. 2007).  
As mentioned above, the target of the 
enzyme is the guanidine group of L-Arg  
(Fig. 2). Together with the catalytically 
important cysteine in PAD, it forms an 
intermediate tetrahedral adduct. Following a 
nucleophile attack of water molecules, the 
ammonia molecule is detached. Finally the 
ketone group is formed (Arita et al. 2004). 
Mammalian PADs have only the ability to 
convert proteinous L-Arg (or L-methyl-Arg) 
to L-Cit and free L-Arg is not modified by 
them (Takahara et al. 1986). This possibility 
possesses only peptidylarginine deiminase 
from Porpyromonas gingivalis, but the 
enzyme is not evolutionary associated with 
mammalian isoforms and its catalysis is 
independent of calcium ions (Rodríguez et al. 
2010). 
 
Conditions of reaction  
The mammalian PAD action is dependent 
on calcium ions. Under physiological 
conditions, the Ca
2+
 concentration in the cell 
is 0,0001 mM, and it is too low to activate the 
enzymes. For example, PAD2 needs about 
100-time higher ion concentration and half of 
its activity is obtained with 40 – 60 mM Ca2+ 
(Takahara et al. 1986; Vossenaar 2004). 
Because of this limitation, there are several 
situations in which activation of PAD is 
possible. 
The first possibility concerns extreme 
conditions such as apoptosis (Asaga et al. 
1998) or epidermis keratinization (Ying et al. 
2012). The cell disintegration allows either 
the calcium ions influx, or enzyme exflux 
(Vossenaar 2004) to the intercellular space 
where the ion concentration is appropriate for 
activation. Alternatively, reservoirs of Ca
2+
 
can be released from the mitochondria and 
endoplasmic reticulum, as is observed in 
prion disease (O’Donovan et al. 2001; 
Ferreiro et al. 2006; Jang et al. 2008). 
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Peptidylarginine deiminase reveals some  
preferences on the primary and secondary 
structure of the substrate. For example: Arg 
located close to Pro is never citrullinated and 
Arg situated in alpha helix is hardly 
deiminated. However, N-Arg-Asp-C  is the 
one of most susceptible region for 
modification, like beta turns (György et al. 
2006). 
 
Figure 2. Mechanism of citrullination. 
 
Citrullination in physiology and disease  
Citrullination is a process which can occur 
in physiological or pathological conditions. In 
physiological processes, deimination play a 
regulatory role of processes such as the 
epidermal keratinization (Senshu et al. 1996), 
regulation of gene expression (Karlić et al. 
2010) and myelin reorganization (Moscarello 
et al. 2002). In the pathogenesis of many 
diseases the reduction of appropriate level of 
protein citrullination was observed (psoriasis). 
On the other hand, the increased levels of L-
Arg citrullination in physiological substrates 
(multiple sclerosis, progression of cancer) and 
modification of proteins that are not a 
physiological substrates for PAD was also 
presented (rheumatoid arthritis)(Vossenaar et 




The skin is mechanical barrier providing 
protection against pathogens, skin-penetrating 
substances, and uncontrolled water loss. A lot 
of evidences point out the significant role of 
the protein citrullination in maintaining of  
the homeostasis and regulation of the 
keratinization process of the epidermis (Ying 
et al. 2012). 
Keratinocytes migrate from the basal to the 
outer part of the epithelium, there they 
gradually die forming the stratum corneum. 
During cell differentiation, the calcium ions 
influx allows the activation of the three 
deiminase isoforms: PAD1, PAD2 and PAD3 
(Vossenaar et al. 2003). Their main substrates 
include: keratin K1, keratin K10, and filaggrin 
(Nachat et al. 2005; Senshu et al. 1996).  
Keratin K1 and K10 are fibrillar proteins 
expressed in the spinous and granular layers 
(Staquet et al. 1987). A deamination within 
keratin K1 concerns two preferred Arg 
residues located at Gly-rich subdomains V1 
and V2. Within them are located the 
association sites for loricrin and desmosomes 
proteins such as desmoplakin (Senshu et al. 
1999; Steinert et al. 1991). The change in the  
isoelectric point of  cytokeratin as the results 
of citrullination improves its ability to interact 
with loricrin (Ishida-Yamamoto et al. 2000). 
It is worth mentioning here that due to a lack 
of Arg, loricrin is not subjected to 
modification. 
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Table 1. Expression of peptidylarginine deiminases in human tissues. 
Enzymes  Expression sites 





colon, brain,ES cel, eye, 
inner ear, placenta, 










Brain, bone marrow, 
breast, colon, lung, 
muscle, skin, ovary, 
synovial membrane,  
synovial fluid 
brain, salivary grand, 
uterus, macrophage, 
spleen, bone marrow, 
skin, synovial fluid, 
synovial membranę 
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Egg, ovary, early embro 
 
The loss of basic character by K1 also 
affects the interaction with filaggrin - an 
important protein in the maintenance of 
epidermal homeostasis. During transition of 
keratinocyte to corneocyte, calpain 1 releases 
filaggrin monomers. These monomers are 
able to interact with keratin. This association 
results in the formation of an intracorneocyte 
fibrous matrix (Pearton et al. 2002). Some 
data suggest that citrullination of the filaggrin 
is crucial to its ability to dissociation and 
production of Natural Moisturizing Factor 
(amino acids constitute 52% of the 
composition)(Tarcsa et al. 1996b; Harding & 
Scott 1983; Ishida-Yamamoto et al. 2000). 
Cytokeratin K1 and K10 are also linked to 
trichohalin (THH). It is an essential structural 
protein responsible for the mechanical 
strength of the hair follicle inner root sheath 
(Tarcsa et al. 1997). After synthesis THH 
form insoluble structures which are stabilized 
by ionic interactions between the alpha 
helices (Lee et al. 1993). During citrullination 
by PAD3, THH aggregates loosen their 
structure, making them more susceptible to 
crosslinking catalyzed by transglutaminase. 
THH complexed with both keratins leads to 
the formation of structures that are stable and 
insoluble in water (Tarcsa et al. 1997). 
Disturbances in the citrullination are 
observed in skin diseases such as psoriasis. 
The disease is characterized by excessive 
activity of skin cell divisions and defective 
cornification. Pathomechanism of psoriasis is 
not fully understood. It is known that 
cytokeratin K1 has reduced number of 
citrullinated L-Arg (Ishida-Yamamoto et al. 
2000). 
 
Regulation of gene expression 
Regulation of gene expression takes place 
on many levels. One of them is the control of 
transcription via modification of histones 
(Karlić et al. 2010). Histones are basic 
proteins which provide a framework for 
organizing the genetic material in a higher-
order structure. One of the possible post-
translational modification acting as a 
regulatory process is citrullination. PAD4 is 
able to modify N-terminal part of the histone 
H2A, H3, H4 (Hagiwara et al. 2005; 
Mastronardi et al. 2006). PAD2 can only 
modify histone H3 (Cherrington et al. 2010). 
PAD competes for the L-Arg with 
methyltransferase, which catalyzes the L-Arg 
methylation. Addition of methyl groups 
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results in sequential formation of mono-, and 
then dimethylderivative of an L-Arg. An 
asymmetric dimethylarginine (both methyl 
groups on one terminal nitrogen) is  
created by coactivator-associated arginine 
methyltransferase 1 (CARM1) and protein 
arginine N-methyltransferase 1 (PRMT1). 
This modification leads to the activation of 
gene expression. However, symmetrical 
dimethylation which is the result of protein 
arginine N-methyltransferase 5 (PRMT5) 
activity, inhibits transcription. PAD4 can 
citrullinate L-Arg, and its monomethylated 
form. Deimination will decondense chromatin 
and prevent the creation of dimethylated L-
Arg derivative. It is worth mentioning that 
dimethyl L-Arg is not a substrate for PAD 
(Thompson & Fast 2006; György et al. 2006).  
Citrullination contributes to the change in 
affinity of the transcription apparatus 
influencing the gene expression (Wysocka et 
al. 2006). Citrullination of histones by PAD4 
correlated for example with repression of 
estrogen-responsive trefoil factor 1 (TFF1) 
gene and apoptosis-associated CDK-
interacting protein 1 (p21) and OKL38 genes. 
PAD2 is involved in the regulation of 
pleiothropin (PTN) and melanoma-associated 
antigen 12 (MAGEA12) genes (Cherrington 
et al. 2012). 
PAD overexpression and changes in their 
subcellular localization is often accompanied 
by certain types of cancer (Mohanan et al. 
2012). Increased levels of PAD4 and its 
activity is presented in invasive carcinomas 
like lung adenocarcinomas, esophageal 
carcinomas with squamous differentiation, 
colorectal adenocarcinomas and bladder 
uterine carcinomas etc. (Wang et al. 2010). 
The progression of cancer is also related to 
the change of PAD2 localization. In the 
normal breast tissues PAD2 is localized in 
both the cytoplasm and the nucleus. Changing 
the location of nuclear PAD2 in certain  
types of cancer may cause changes in  
gene expression and cause malignant 
transformation (Mohanan et al. 2012). 
 
Creation and reorganization of myelin sheaths 
A myelin sheath is formed by 
oligodendrocytes in the central nervous 
system, and Schwann cells in the peripheral 
nervous system. The main purpose of the 
myelin sheath is electrically isolation of axon 
and an increase in the speed of propagation of 
an electrical impulse along the myelinated 
fiber (Kursula 2008). 
Myelin sheaths are composed of proteins, 
like myelin basic protein (MBP) and lipid 
components. The protein molecules are basic. 
They interact with negatively charged lipids 
like gangliosides and phosphatidylserine. 
Lipid-protein interaction is a key element in 
the sheath formation (Boggs et al. 1999). 
Native MBP are able to form a tight, compact 
structure. Such a structure is not conducive to 
its reorganization. The mutual interaction of 
molecules may be affected by frequent post-
translational modifications within the MBP 
including citrullination, deamidation and 
methylation. The change in the isoelectric 
point of the protein after modification 
significantly influences the sheaths relaxation 
(Beniac et al. 2000). 
The enzyme involved in the citrullination 
of MBP is PAD2. The highest PAD2 
expression is observed in the gray matter and 
the hypothalamus (Kubilus & Baden 1983). It 
is known that the amount of deiminated MBP 
changes dramatically during life. In children 
under 2 years old, almost all MBP are 
modified. The degree of citrullination 
correlates with the observed brain plasticity 
(Moscarello et al. 1994). The number of 
modified proteins decreases with age. In the 
adult brain, the amount of citrullinated MBP 
remains constant and represents about 20% of 
the total pool of MBP (Moscarello et al. 
2002). 
Hyper-citrullination of proteins is observed 
in various neurodegenerative diseases such as 
multiple sclerosis. Modification of MBP 
applies not only to the percentage of modified 
proteins (increase from 20% to 45%), but also 
to the amount of citrullinated L-Arg (increase 
from 6 to 18 residues) (Moscarello et al. 
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1994; Wood et al. 1996). It is noted that 
excessive citrullination may occur during a 
reduced methylation as a result of a lowered 
methyltransferase activity (György et al. 
2006). 
Hyper-citrullination of MBP contributes to 
the development of the autoimmune response. 
Modified MBP are more susceptible to 
degradation of cathepsin D. PAD2 is localized 
in CNS myelin and presents elevated activity 
in multiple sclerosis (MS) (Berlet 1987). The 
reaction is approximately 35x faster in 
comparison to native MBP (Cao et al. 1999). 
Peptide released by cathepsin D contains an 
immunodominant epitope (Pritzker et al. 
2000). Immune cells such as lymphocytes 
infiltrate into nerve tissue cause: oxidative 
stress, local inflammation and myelin sheath 
destruction underlying demyelinating disease 
(Whitaker et al. 1980). 
 
Blood clot formation 
The clot is a structure formed by the 
components of the blood to stop bleeding and 
repair the damaged blood vessel. One of  
the main proteins involved in the  
blood coagulation cascade is fibrinogen. 
Structurally, this is a dimeric glycoprotein. 
The release of fibrinopeptides A and B from 
fibrinogen, catalyzed by thrombin, results in 
the formation of monomers with exposed 
polymerization sites. Monomers organize 
themselves spontaneously and form a labile 
and then cross-linked stable fibrin. Finally, 
red cells and platelets adhere to resulting 
structure and form a clot (Blombäck et al. 
1978; Furie & Furie 1988; Nakayama-
Hamada et al. 2008). 
Extravascular clot formation usually 
accompanies inflammatory processes for 
instance rheumatoid arthritis (RA). RA is a 
systemic autoimmune disease characterized 
by inflammation of peripheral joint which 
leads to cartilage destruction and joint 
dysfunction (Firestein 2003). During the 
infiltration of inflammatory synovium, 
monocytes differentiate into macrophages and 
subsequently become activated. Sustained 
activation makes them susceptible to 
programmed death. During the macrophage 
apoptosis, PAD2 and PAD4 are activated and 
then leaked into the synovium (Rodenburg et 
al. 2000; Vossenaar 2004). Damaged cell 
products stimulate the retraction of 
endothelial cells, which facilitates the 
extravasation of fibrinogen and other  
plasma components (Méchin et al. 2007). 
Citrullination can indeed occur within the 
rheumatoid synovial tissue with many 
different L-Arg residues citrullinated in 
different proteins including fibrinogen 
(Okumura et al. 2009; Vossenaar 2004). 
Cleavage sites for thrombin are located on 
the N-terminus of Aα and Bβ chains of 




 in the 
Aα chain and Arg14-Gly15 in Bβ chain. 
Deimination blocks the releasing of 
fibrinopeptides because of L-Arg 
modification and thus prevents the 
polymerization of fibrin. Citrullinated 
fibrinogen in this case acts as an 
uncompetitive inhibitor of thrombin reaction 
(Nakayama-Hamada et al. 2008). In addition, 
certain fibrinogen molecules can be converted 
to fibrin before deimination. It is perhaps 
possible due to the increased level of 
thrombin in the synovial fluid (So et al. 2003) 
After fibrin citrullination, a reduction 
ability to degradation it by plasmin can also 
be observed. This serine proteinase cleaves 
the peptide bond near basic amino acids such 
as Lys and Arg. Deimination reduces the 
number of potential degradation sites (Sebbag 
et al. 2004).  
Currently, it is unknown whether the 
formation of fibrinogen deposits is a primary 
or secondary cause of the disease. However, it 
is known that fibrinogen can stimulate an 
immune response in two ways; directly across 
immunogenic citrullinated alpha and beta 
chains (Masson-Bessière et al. 2001) and 
indirectly by stimulating production of IL-1, 
IL-8, IL-13 and TNF-alpha by macrophages, 
resulting in extravasation of fibrinogen and a 
cyclic  process (Rubin & Sønderstrup 2004). 
 




CITRULLINATION – SMALL CHANGE WITH A GREAT CONSEQUENCE  23 
 
Conclusion 
Citrullination has been observed in many 
physiological and pathological processes. 
Modification can drastically change the 
properties and thus the function of the protein. 
However, we should note, that the 
citrullination have mainly regulatory 
functions and its role in pathogenic processes 
is possible only under certain conditions. 
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